Skip to main content
TipRanks
Go Ultimate75% OFF

Kevin DAmour Insider Profile

4 Followers

Kevin DAmour, CSO at Eterna Therapeutics, holds 11.50K shares in Eterna Therapeutics (Ticker: ERNA).

Kevin DAmour's Trading History

ERNA
Eterna Therapeutics
Jun 29, 2022CSOUninformative Buy6.32K$19.43K
ERNA
Insider Shares: 11.50K (0.02%)

Kevin DAmour has not reported any informative transactions for ERNA, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 29, 2022Uninformative Buy$6.32K11,496$0.55―

You May Also Like

Kevin DAmour insider profile FAQ

What stocks does Kevin DAmour hold?
Kevin DAmour holds: ERNA stocks.
What was Kevin DAmour’s latest transaction?
Kevin DAmour’s latest transaction was an Uninformative Buy of $6.32K.
What is Kevin DAmour's role in Eterna Therapeutics?
Kevin DAmour's role in Eterna Therapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.